NCT00586898View on ClinicalTrials.gov

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
ProstateCancerHormonal Cycling
Interventions
DRUG

GnRH

leuprolide and goserelin are gonadotropin-releasing hormone analogues

DRUG

Ketoconazole

An imidazole antifungal agent. reduces adrenal and testicular androgen production in men

DRUG

Bicalutamide

A pure nonsteroidal antiandrogen

DRUG

Testosterone transdermal gel

an androgenic anabolic steroid

DRUG

Estrogen transdermal patch

Estradiol is the primary and most potent estrogen

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00586898 - Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | Biotech Hunter | Biotech Hunter